Acadia Pharma (ACAD) Misses Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $30.21 +0.10%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
TWIN, FLO, ATHM, More
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
TWIN, FLO, ATHM, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Jaguar Health (JAGX) Tops Q2 EPS by 3647c
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
